Liability for defective products – Major changes (potentially) brought by the revised Product Liability Directive
Category: Trade Practices & Consumer Law
On 12 March 2024, the European Parliament adopted its position at first reading with respect to the proposal for a new Directive on liability for defective products1 (the “revised (Product Liability) Directive” or the “revised PLD”). If adopted by the Council, this new Directive will repeal and replace Directive 85 / 374 / EEC (the “current PLD”) and bring several major changes in the four-decade-old no fault-based manufacturer liability regime for damage caused by defective products, currently governed in Belgium by the Act of 25 February 1991. Discover below a few of them.
Broader definition of a "product" for the digital age
The revised PLD would still provide for a right to compensation for any natural person who suffers damage caused by a defective product that has first be made available or used in the course of a commercial activity in the Union market. However, the revised PLD would redefine such “product” as “all movables, even if integrated into, or inter-connected with, another movable or an immovable”, including electricity and raw materials (such as gas and water) and – and this is new – “digital manufacturing files and software”.
The revised PLD justifies the inclusion of software into the definition of a product as follows: “Software, such as operating systems, firmware, computer programs applications, or AI systems, is increasingly common on the market and plays an increasingly important role for product safety. Software is capable of being placed on the market as a standalone product or can subsequently be integrated into other products as a component, and it is capable of causing damage through its execution” (Recital 13). The Recital furthermore adds: “A developer or producer of software, including AI system providers within the meaning of Regulation (EU) 2024/... [laying down harmonised rules on artificial intelligence (AI Act)], should be treated as a manufacturer”. Unsurprisingly, a special emphasis on damages caused by AI systems is deemed useful.
A carve-out would however be provided for free and open-source software developed or supplied outside the course of a commercial activity, this in order not to hamper innovation or research (see Recitals 14-15 and Art. 2(2) of the revised PLD).
The no-fault liability regime would not only apply to damage caused by a defective “product”, but also by a defective “component” that was integrated into, or inter-connected with, a product within the manufacturer’s control (i.e., by the manufacturer of the product or with his/her authorisation) and caused that product to be defective. Such “component” would be defined as “any item, whether tangible or intangible, or raw material or any related service, that is integrated into, or inter-connected with, a product”. Importantly, this would include, a.o., software updates and upgrades. Moreover, a “related service” would be understood as “a digital service that is integrated into, or inter-connected with, a product in such a way that its absence would prevent the product from performing one or more of its functions”. Recital 17 of the revised PLD provides several examples of such “related services”: “[...] the continuous supply of traffic data in a navigation system, a health monitoring service that relies on a physical product’s sensors to track the user’s physical activity or health metrics, a temperature control service that monitors and regulates the temperature of a smart fridge, or a voice-assistant service that allows one or more products to be controlled by using voice commands”.
“Digital manufacturing files”, on its part, would cover “a digital version of, or digital template for, a movable which contains the functional information necessary to produce a tangible item by enabling the automated control of machinery or tools”. Here, you can think about 3D-printing files. Recital 16 of the revised PLD indeed provides for the following example: “A defective computer-assisted-design file used to create a 3D-printed good that causes harm should give rise to liability under this Directive, where such a file is developed or supplied in the course of a commercial activity”.
All in all, it seems that the 40-year-old “product” definition will be dusted off and adapted to the digital age, thereby generating a major broadening of the material scope of the no-fault liability regime.
Broader range of damages to be compensated
Under the current PLD, manufacturers are liable for defective products which have caused death, personal injury or damage to/destruction of property (except the defective product itself).
Under the revised PLD, manufacturers would be liable for compensating material and – insofar as they can be compensated for under national law, which is the case in Belgium – non-material losses resulting: from death or personal injury, including medically recognised damage to psychological health; from damage to property (except the defective product itself or the product damaged by a defective component, and property used exclusively for professional purposes); and from destruction or corruption of data that are not used for professional purposes.
Alleviation of the burden of proof:
Presumption of defectiveness and causality
and right to disclosure of evidence
Under the current PLD, the burden of proof of the defectiveness of the product, the damage suffered and the causal relationship between defect and damage lies with the injured person.
This would remain the case under the revised PLD, with the two following major caveats:
Where an injured party claiming compensation in national proceedings for damage caused by a defective product would have presented “facts and evidence sufficient to support the plausibility of the claim for compensation”, the manufacturer could be required, at the request of said injured party, to “disclose relevant evidence that is at [its] disposal”. A similar disclosure obligation would be imposed on the injured party at the request of the manufacturer, where the manufacturer would have presented “facts and evidence sufficient to demonstrate the [manufacturer’s] need for evidence for the purposes of countering a claim for compensation”.
Such disclosure of evidence should be limited to what is “necessary and proportionate”, and protection of confidential information and trade secrets should be taken into account by the national courts when assessing such character. Quite interestingly, Art. 9(7) of the revised PLD requires Member States to ensure that “where a party is required to disclose evidence, national courts are empowered [...] to require such evidence to be presented in an easily accessible and easily understandable manner, if such presentation is deemed proportionate by the national court in terms of costs and effort for the required party”. This could prove very useful for injured parties having suffered damage caused by complex defective products, such as AI systems;
The burden of proof for the injured party would furthermore be facilitated by the establishment, under certain conditions, of a presumption of defectiveness and a presumption of causal link.
Defectiveness of the product would be presumed where the manufacturer would fail to comply with the disclosure obligation referred to above or where the injured person would demonstrate that the product does not comply with mandatory product safety requirements intended to protect against the risk of the damage suffered by the injured person or that the damage was caused by an obvious malfunction of the product during reasonably foreseeable use or under ordinary circumstances.
Defectiveness of the product and/or causal link between such defectiveness and the damage would be presumed where, despite the disclosure of evidence referred to above, the injured person would face “excessive difficulties, in particular due to technical or scientific complexity, in proving the defectiveness of the product or the causal link between its defectiveness and the damage, or both”, or the injured party would demonstrate that such defectiveness and/or causal link are “likely”. Recital 48 of the revised PLD states that “technical or scientific complexity should be determined by national courts on a case-by-case basis, taking into account various factors. Those factors should include the complex nature of the product, such as an innovative medical device; the complex nature of the technology used, such as machine learning; the complex nature of the information and data to be analysed by the claimant; and the complex nature of the causal link, such as a link between a pharmaceutical or food product and the onset of a health condition or a link that, in order to be proven, would require the claimant to explain the inner workings of an AI system. The assessment of excessive difficulties should also be made by national courts on a case-by-case basis. While a claimant should provide arguments to demonstrate excessive difficulties, proof of such difficulties should not be required. For example, in a claim concerning an AI system, the claimant should, for the court to decide that excessive difficulties exist, neither be required to explain the AI system’s specific characteristics nor how those characteristics make it harder to establish the causal link”.
The trialogue negotiations must now continue and it is up to the Council to adopt its own position on the proposal. Stay tuned for updates.
In the meantime, feel free to reach out to our Trade Practices & Consumer Law specialists via ip/it-team@liedekerke.com or visit our dedicated page via the link below.
1Available here: https://www.europarl.europa.eu/doceo/document/TA-9-2024-0132_EN.html